Evidence map›Paper›PMID 29607101›Full record

ReviewBMJ global health2018

Weak surveillance and policy attention to cancer in global health: the example of Mozambique.

Cesaltina Lorenzoni, Laura Oliveras, Alba Vilajeliu, Carla Carrilho, Mamudo R Ismail, Paola Castillo, Orvalho Augusto, Mohsin Sidat, Clara Menéndez, Alberto L Garcia-Basteiro and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in BMJ global health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Cesaltina Lorenzoni *Department of Pathology, Maputo Central Hospital, Maputo, Mozambique.
Laura Oliveras *ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Alba Vilajeliu *ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Carla CarrilhoDepartment of Pathology, Maputo Central Hospital, Maputo, Mozambique.
Mamudo R IsmailDepartment of Pathology, Maputo Central Hospital, Maputo, Mozambique.
Paola CastilloISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Orvalho AugustoCommunity Health Department, Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.
Mohsin SidatCommunity Health Department, Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.
Clara MenéndezISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Alberto L Garcia-BasteiroISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Jaume OrdiISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Universitat de Barcelona · ESEduardo Mondlane University · MZBarcelona Institute for Global Health · ESMaputo Central Hospital · MZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is an emerging public health problem in sub-Saharan Africa due to population growth, ageing and westernisation of lifestyles. The increasing burden of cancer calls for urgent policy attention to develop cancer prevention and control programmes. Cancer surveillance is an essential prerequisite. Only one in five low-income and middle-income countries have the necessary data to drive policy and reduce the cancer burden. In this piece, we use data from Mozambique over a 50-year period to illustrate cancer epidemiological trends in low-income and middle-income countries to hypothesise potential circumstances and factors that could explain changes in cancer burden and to discuss surveillance weaknesses and potential improvements. Like many low-income and middle-income countries, Mozambique faces the dual challenge of a still high morbidity and mortality due to infectious diseases in rural areas and increased incidence of cancers associated with westernisation of lifestyles in urban areas, as well as a rise of cancers related to the HIV epidemic. An increase in cancer burden and changes in the cancer profile should be expected in coming years. The Mozambican healthcare and health-information systems, like in many other low-income and middle-income countries, are not prepared to face this epidemiological transition, which deserves increasing policy attention.

Indexed as

Cancerlow- and middle-income countriesMozambiqueregistrysurveillance

Identifiers

PMID29607101
PMCPMC5873532
OpenAlexW2791565597

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.